Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Erlotinib Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,939Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Accord healthcare

    02 3Alembic Pharmaceuticals Limited

    03 6Apotex Inc

    04 3Astellas Pharma

    05 3Aurobindo Pharma Limited

    06 2Chartwell Pharmaceuticals llc

    07 3Cheplapharm Arzneimittel Gmbh

    08 3Cipla

    09 3Cipla Medpro South Africa

    10 3Eurolab

    11 6F. Hoffmann-La Roche

    12 2Fujian South Pharmaceutical

    13 5Hetero Drugs

    14 4Krka

    15 3MSN Laboratories

    16 3Natco Pharma

    17 3Natco Pharma (Canada) Inc

    18 2Nishchay Pharmaceuticals Pvt. Ltd.

    19 1Pharmascience Inc.

    20 3Rising Pharmaceuticals Inc

    21 3STADA Arzneimittel

    22 6Sandoz B2B

    23 3Shilpa Medicare

    24 2Sudair Pharma

    25 6Sun Pharmaceutical Industries Limited

    26 3Tarbis Farma Sl

    27 15Teva Pharmaceutical Industries

    28 3Tillomed Laboratories Ltd

    29 3Viatris

    30 3Zydus Pharmaceuticals

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Apotex Inc

    Canada
    BIO-Europe Spring
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    BIO-Europe Spring
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Apotex Inc

    Canada
    DCAT Week
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Apotex Inc

    Canada
    DCAT Week
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Astellas Pharma

    Japan
    DCAT Week
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Astellas Pharma

    Japan
    DCAT Week
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Astellas Pharma

    Japan
    DCAT Week
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Chartwell Pharmaceuticals llc

    U.S.A
    DCAT Week
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Chartwell Pharmaceuticals llc

    U.S.A
    DCAT Week
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Hetero Drugs

    India
    DCAT Week
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Hetero Drugs

    India
    DCAT Week
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Hetero Drugs

    India
    DCAT Week
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Natco Pharma

    India
    DCAT Week
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Natco Pharma

    India
    DCAT Week
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Natco Pharma

    India
    DCAT Week
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Rising Pharmaceuticals Inc

    U.S.A
    DCAT Week
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Rising Pharmaceuticals Inc

    U.S.A
    DCAT Week
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Rising Pharmaceuticals Inc

    U.S.A
    DCAT Week
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Teva Pharmaceutical Industries

    Israel
    DCAT Week
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2020-11-09

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Teva Pharmaceutical Industries

    Israel
    DCAT Week
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Teva Pharmaceutical Industries

    Israel
    DCAT Week
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    DCAT Week
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.